Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
20 Mar 2024 - PainChek Limited (ASX:PCK) CEO Philip Daffas provides an overview of the company, discussing its recent agreement with Nourish Care to expand into the UK market.
05 May 2022 - Torian Resources Limited (ASX:TNR) Executive Chairman Paul Summers and Senior Geologist Claudio Sheriff discuss the significance of the company's rare earths discovery.
18 Sep 2024 - Venkata Gutta, CEO and Founder of MILLIBEAM, discusses the company’s mission to make millimetre-wave technology cost-effective and scalable.
31 Jan 2020 - Los Cerros Limited (ASX:LCL) Managing Director, Jason Stirbinskis, talks about the company's gold projects in Colombia, the potential for high grade porphyry despots and plans to advance drilling at its Chuscal target.
10 Jul 2024 - The Honourable Shane Jones discusses the New Zealand government's pro-mining strategy. Topics touched on include: the rationale behind invigorating the resources sector, statutory reforms to boost investment, and commodities New Zealand possesses.
21 Oct 2024 - Ken Morrison, CEO of the Bradfield Development Authority, discusses building Australia's first new city in a century, a high-tech urban project linked to the new Western Sydney International Airport.
03 Nov 2023 - Vital Metals (ASX:VML) Chairman Richard Crookes shares exclusive insights on Nechalacho, Rare Earth projects, and the company's strategic partnerships, offering a compelling overview of their journey and future prospects.